Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
100.6 PLN | 0.00% | -0.59% | +4.90% |
Sales 2024 * | 2.33B 569M | Sales 2025 * | 2.55B 621M | Capitalization | 2B 487M |
---|---|---|---|---|---|
Net income 2024 * | 48M 11.71M | Net income 2025 * | 179M 43.66M | EV / Sales 2024 * | 1.08 x |
Net Debt 2024 * | 533M 130M | Net Debt 2025 * | 472M 115M | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
41.2
x | P/E ratio 2025 * |
12.2
x | Employees | 1,446 |
Yield 2024 * |
3.73% | Yield 2025 * |
5.22% | Free-Float | 15.74% |
1 week | -0.59% | ||
Current month | -2.71% | ||
1 month | -3.82% | ||
3 months | +3.07% | ||
6 months | +4.79% | ||
Current year | +4.90% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 98-12-31 | |
Robert Pabich
BRD | Director/Board Member | - | 14-11-11 |
Marlena Matusiak
IRC | Investor Relations Contact | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 93-12-31 | |
Alfred Pelzer
CHM | Chairman | 65 | - |
Director/Board Member | - | 04-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 100.6 | 0.00% | 2,970 |
24-04-15 | 100.6 | -0.98% | 1,298 |
24-04-12 | 101.6 | 0.00% | 2,406 |
24-04-11 | 101.6 | -0.39% | 3,402 |
24-04-10 | 102 | +0.79% | 655 |
Delayed Quote Warsaw S.E., April 16, 2024 at 11:55 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.90% | 494M | |
+11.26% | 62.63B | |
-4.35% | 46.26B | |
+11.37% | 39.35B | |
+20.17% | 26.96B | |
+1.54% | 17.85B | |
-0.52% | 17.38B | |
+3.47% | 15.46B | |
-26.46% | 14.73B | |
-20.81% | 14.16B |
- Stock Market
- Equities
- PCR Stock